Published in J Autoimmun on August 01, 2004
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2008) 1.75
CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc Natl Acad Sci U S A (2005) 1.27
Modeling the heterogeneity of multiple sclerosis in animals. Trends Immunol (2013) 1.25
Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol (2009) 1.21
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci (2013) 1.17
Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur J Immunol (2006) 1.16
Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J Immunol (2011) 1.12
The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol (2014) 1.11
Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development. J Immunol (2011) 1.06
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis. Clin Exp Immunol (2005) 0.91
Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency. J Neuroimmunol (2007) 0.87
Tissue-resident exhausted effector memory CD8+ T cells accumulate in the retina during chronic experimental autoimmune uveoretinitis. J Immunol (2014) 0.84
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection. Neurotherapeutics (2015) 0.83
TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells. J Immunol (2014) 0.82
Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. PLoS One (2013) 0.81
Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol Commun (2014) 0.80
Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination. Semin Immunopathol (2010) 0.79
Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen. Mol Ther (2009) 0.79
Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis. Mol Neurobiol (2016) 0.78
Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation. J Neuroimmunol (2007) 0.78
β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice. Eur J Immunol (2016) 0.78
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: another aspect of immune privilege in the CNS. Eur J Immunol (2012) 0.76
Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8⁺ T cells derived from autoantigen-deficient mice. Front Immunol (2011) 0.76
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function. J Immunol (2015) 0.76
Regulatory lymphocytes are key factors in MHC-independent resistance to EAE. J Immunol Res (2014) 0.75
Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy. J Neuroimmunol (2017) 0.75
Error propagation and scaling for tropical forest biomass estimates. Philos Trans R Soc Lond B Biol Sci (2004) 5.62
Plant DNA barcodes and a community phylogeny of a tropical forest dynamics plot in Panama. Proc Natl Acad Sci U S A (2009) 5.27
Simplicity belies a complex system: a response to the minimal model of immunity of Langman and Cohn. Cell Immunol (2002) 2.90
Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood (2006) 2.67
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A (2008) 2.57
Stereotype content model across cultures: towards universal similarities and some differences. Br J Soc Psychol (2009) 2.56
Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest (2006) 2.53
Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol (2006) 2.28
Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest (2007) 2.00
Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol (2004) 1.71
Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci U S A (2004) 1.69
Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68
T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif. FASEB J (2006) 1.57
T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J (2003) 1.56
Emergent dynamics of thymocyte development and lineage determination. PLoS Comput Biol (2006) 1.49
Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation. Genome Res (2003) 1.48
Heat shock proteins as endogenous adjuvants in sterile and septic inflammation. J Immunol (2005) 1.44
The immune-body cytokine network defines a social architecture of cell interactions. Biol Direct (2006) 1.41
Retracted Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal. Diabetes Care (2014) 1.38
Nations' income inequality predicts ambivalence in stereotype content: how societies mind the gap. Br J Soc Psychol (2012) 1.37
Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol (2005) 1.35
Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med (2009) 1.34
Directional changes in the species composition of a tropical forest. Ecology (2011) 1.33
The HSP60 immune system network. Trends Immunol (2010) 1.33
Four-dimensional realistic modeling of pancreatic organogenesis. Proc Natl Acad Sci U S A (2008) 1.29
Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol (2007) 1.24
Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol (2002) 1.23
Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data. Proc Natl Acad Sci U S A (2009) 1.14
DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J Immunol (2003) 1.13
Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J Immunol (2005) 1.09
An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology (2010) 1.08
Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity. J Autoimmun (2003) 1.08
TLR2-dependent inflammatory response to Porphyromonas gingivalis is MyD88 independent, whereas MyD88 is required to clear infection. J Immunol (2009) 1.06
Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome. Eur J Immunol (2002) 1.05
Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. J Autoimmun (2007) 1.02
Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation. J Immunol (2005) 1.01
Propagation of lewis rat encephalitogenic T cell lines: T-cell-growth-factor is superior to recombinant IL-2. J Neuroimmunol (2002) 1.01
Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer. Eur Urol (2010) 1.00
1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients. Cancer Biol Ther (2007) 0.99
Liana abundance, diversity, and distribution on Barro Colorado Island, Panama. PLoS One (2012) 0.99
Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression. Arterioscler Thromb Vasc Biol (2012) 0.98
The natural autoantibody repertoire and autoimmune disease. Biomed Pharmacother (2004) 0.98
Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. Eur J Immunol (2006) 0.98
Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol (2002) 0.98
Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients. Hum Vaccin (2010) 0.96
HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J Clin Invest (2005) 0.96
DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J Immunol (2002) 0.96
Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients. Diabetes Metab Res Rev (2007) 0.95
The natural autoantibody repertoire in newborns and adults: a current overview. Adv Exp Med Biol (2012) 0.94
A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice. PLoS One (2009) 0.94
The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys. J Neuroimmunol (2006) 0.94
Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum (2004) 0.93
Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation. PLoS One (2008) 0.92
T cells and autoantibodies to human HSP70 in type 1 diabetes in children. J Autoimmun (2003) 0.92
HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation. PLoS Pathog (2010) 0.92
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). J Neuroinflammation (2012) 0.91
NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function. Ann N Y Acad Sci (2006) 0.91
Tolerance and immunity in a mathematical model of T-cell mediated suppression. J Theor Biol (2003) 0.91
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol (2011) 0.91
HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. J Immunol (2009) 0.90
Signaling via TLR2 and TLR4 Directly Down-Regulates T Cell Effector Functions: The Regulatory Face of Danger Signals. Front Immunol (2013) 0.90
Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice. J Neurosci Res (2003) 0.89
Cannabinoids decrease the th17 inflammatory autoimmune phenotype. J Neuroimmune Pharmacol (2013) 0.89
Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J Immunol (2006) 0.88
How regulatory CD25+CD4+ T cells impinge on tumor immunobiology: the differential response of tumors to therapies. J Immunol (2007) 0.87
HSP60 as a target of anti-ergotypic regulatory T cells. PLoS One (2008) 0.87
IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice. J Immunol (2009) 0.87
Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies. Immunology (2010) 0.86
Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis. Int Immunol (2006) 0.86
D-enantiomer peptide of the TCRalpha transmembrane domain inhibits T-cell activation in vitro and in vivo. FASEB J (2005) 0.86
Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene. J Clin Invest (2002) 0.86
HSP60 speaks to the immune system in many voices. Novartis Found Symp (2008) 0.86
A structurally altered D,L-amino acid TCRalpha transmembrane peptide interacts with the TCRalpha and inhibits T-cell activation in vitro and in an animal model. Biochemistry (2007) 0.85
Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling. J Leukoc Biol (2004) 0.85
Retracted Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care (2014) 0.85
DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response. J Clin Invest (2004) 0.85
Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor. Biochemistry (2008) 0.85
How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors. J Theor Biol (2007) 0.84
Network theory analysis of antibody-antigen reactivity data: the immune trees at birth and adulthood. PLoS One (2011) 0.84
Heat shock protein 60, via MyD88 innate signaling, protects B cells from apoptosis, spontaneous and induced. J Immunol (2009) 0.84
Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid. J Immunol (2003) 0.84
Inverse correlation between the incidences of autoimmune disease and infection predicted by a model of T cell mediated tolerance. J Autoimmun (2004) 0.83
G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: a possible mechanism for exacerbation of multiple sclerosis. J Neuroimmunol (2006) 0.83
Analyses of antigen dependency networks unveil immune system reorganization between birth and adulthood. Chaos (2011) 0.83
A highly conserved sequence associated with the HIV gp41 loop region is an immunomodulator of antigen-specific T cells in mice. Blood (2013) 0.83
Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine. Vaccine (2008) 0.83
OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207. Eur J Immunol (2007) 0.83
Identification of aldolase as a target antigen in Alzheimer's disease. J Immunol (2005) 0.83
Proliferation and competition in discrete biological systems. Bull Math Biol (2003) 0.83
Monoclonal antibody to a DNA-binding domain of p53 mimics charge structure of DNA: anti-idiotypes to the anti-p53 antibody are anti-DNA. Eur J Immunol (2004) 0.82
Autoimmune encephalomyelitis and uveitis induced by T cell immunity to self beta-synuclein. J Immunol (2003) 0.82